Industry expert argues that President Donald Trump's omission of Bitcoin and crypto in Tuesday's congressional address puts his policy position in doubt. Over the past year, President Donald Trump has ...

In a report released today, Krish Sankar from TD Cowen reiterated a Buy rating on Silvaco Group, Inc. (SVCO – Research Report), with a price ...

Calumet Specialty Products Partners (NASDAQ:CLMT – Get Free Report) was downgraded by research analysts at TD Cowen from a ...

Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports.

Investment bank TD Cowen noted that President Donald Trump did not mention cryptocurrency in his Congress speech.

Economic forecasts have been weakening. While some see slower growth, several commentators see the chance of an outright ...

Moderna, Inc. ( NASDAQ: MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ET All right, well, good morning, everyone. Tyler Van Buren here, Senior Biotech Analyst at TD Cowen.

Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...

We recently compiled a list of the 10 Best Performing Fintech Stocks to Buy According to Analysts. In this article, we are ...

In a report released today, Brendan Smith from TD Cowen maintained a Buy rating on Repligen (RGEN – Research Report), with a price target of ...

The newly listed clinical-stage biotechnology company, Metsera Inc. rose 15.01% on Monday as the broader markets declined.

Merck’s stock has fallen 7.27% year-to-date, raising investor concerns. Despite a 1.84% gain on Friday, the stock remains ...